ArticleOncoTargets and therapy2018

Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies.

Xinming Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.